By Dr Sradha Srinivasa Kotwal

Journal articles

Yin X; Huang L; Tian M; Song H; Ding X; Jha V; Kotwal S; Marklund M; Liu Y; Zhang X; Wu Y; Trieu K; Neal B, 2025, 'Risks of Hyperkalemia With Potassium-Enriched Salt Substitute Among Patients Using Concomitant Blockade of the Renin-Angiotensin-Aldosterone System in the Salt Substitute and Stroke Study', Circulation, 152, pp. 1311 - 1313, http://dx.doi.org/10.1161/CIRCULATIONAHA.125.075690

Ketema DB; Jun M; Kotwal S; Hailu W; Gallagher M; Joshi R, 2025, 'Stakeholders' perspectives on barriers and enablers of chronic kidney disease care in Ethiopia: A qualitative study', Plos One, 20, http://dx.doi.org/10.1371/journal.pone.0336781

Sasaki T; Buizen L; Harris K; Badve SV; Chalmers J; Gallagher M; Ha JT; Jardine MJ; Ketema D; Kotwal SS; Neuen BL; Ronksley PE; Wallace H; Yokoo T; Woodward M; Jun M, 2025, 'Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality: A Retrospective Observational Study Based on National General Practice Dataset.', Kidney360, http://dx.doi.org/10.34067/kid.0000000988

Li AK; Kotwal S; Wallace H; Ketema DB; Wick J; Neuen BL; Falster MO; Lin J; Pearson SA; Peiris D; Jardine MJ; Woodward M; Chalmers J; Ronksley PE; Jun M, 2025, 'Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset', BMJ Open, 15, pp. e096730 - e096730, http://dx.doi.org/10.1136/bmjopen-2024-096730

Davis G; Kim D; Jun M; Kotwal SS, 2025, 'Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management', Heart Lung and Circulation, 34, pp. 1060 - 1068, http://dx.doi.org/10.1016/j.hlc.2025.05.095

Wallace H; Wick J; Neuen BL; Buizen L; Badve SV; Chalmers J; de Oliveira Costa J; Falster MO; Ha JT; Jardine MJ; Ketema DB; Lin J; Nelson C; Pearson SA; Peiris D; Rodgers A; Sasaki T; Woodward M; Gallagher M; Kotwal SS; Ronksley P; Jun M, 2025, 'Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset', Diabetes Obesity and Metabolism, 27, pp. 5599 - 5611, http://dx.doi.org/10.1111/dom.16608

Ketema DB; Wallace H; Hailu W; Badve SV; Ronksley P; Neuen BL; Pecoits-Filho R; Gallagher M; Kotwal S; Perkovic V; Joshi R; Jun M, 2025, 'Quality of care for people with chronic kidney disease: a systematic review and meta-analysis', BMJ Open, 15, http://dx.doi.org/10.1136/bmjopen-2025-102044

Beal B; Buizen L; Yeung EK; Heath L; Houston L; Cherney DZI; Jardine M; Pollock C; Arnott C; Kotwal SS; Heerspink HJL; Perkovic V; Neuen BL, 2025, 'Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: Insights from the CREDENCE trial', Nephrology Dialysis Transplantation, 40, pp. 1727 - 1735, http://dx.doi.org/10.1093/ndt/gfaf044

Lazarus B; Polkinghorne KR; Gallagher MP; Catiwa J; Gray NA; Coggan S; Higgins KR; Talaulikar G; McDonald AM SP; Kotwal S, 2025, 'The epidemiology of haemodialysis catheter infections in Australia, 2016–20: a prospective cohort study', Medical Journal of Australia, 223, pp. 248 - 256, http://dx.doi.org/10.5694/mja2.70014

Jeyaruban A; Bose B; Lee VW; Jardine M; Mallawaarachchi A; Ritchie A; Wong MG; Makris A; Badve SV; Siriwardana A; Yong K; Perkovic V; Kotwal S, 2025, 'Glomerular disease registry and biobank: design and baseline results', Internal Medicine Journal, 55, pp. 1301 - 1307, http://dx.doi.org/10.1111/imj.70056

Lazarus B; Kotwal S; Gallagher M; Higgins K; Coggan S; Gray NA; Talaulikar G; Polkinghorne KR, 2025, 'Prophylactic Antibiotics Before Insertion of Tunneled Hemodialysis Catheters: A Nationwide Cohort Study', Kidney Medicine, 7, http://dx.doi.org/10.1016/j.xkme.2025.101042

Potter D; Polkinghorne KR; Conway A; Davies CE; Au E; Pilmore A; Kulkarni H; Roberts MB; Kolovos P; Dendle C; Menahem S; Kotwal S, 2025, 'Changes in Dialysis Practice Patterns in Australia and New Zealand During the COVID-19 Pandemic Period', Nephrology, 30, http://dx.doi.org/10.1111/nep.70077

Zhu Y; Jun M; Fletcher RA; Arnott C; Neuen BL; Kotwal SS, 2025, 'Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial', Diabetes Obesity and Metabolism, 27, pp. 3531 - 3535, http://dx.doi.org/10.1111/dom.16363

Harel Z; Smyth B; Badve SV; Blum D; Beaubien-Souligny W; Silver SA; Clark E; Suri R; Mavrakanas TA; Sasal J; Prasad B; Eikelboom J; Tennankore K; Rigatto C; Prce I; Madore F; Mac-Way F; Steele A; Zeng Y; Sholzberg M; Dorian P; Yan AT; Sood MM; Gladstone DJ; Tseng E; Kitchlu A; Walsh M; Sapir D; Oliver MJ; Krishnan M; Kiaii M; Wong N; Kotwal S; Battistella M; Acedillo R; Lok C; Weir M; Wald R, 2025, 'Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial', Journal of the American Society of Nephrology, 36, pp. 901 - 910, http://dx.doi.org/10.1681/ASN.0000000000000495

Wallace H; Wick J; Ketema DB; Buizen L; Woodward M; Peiris D; Neuen BL; Robertson C; Nelson C; Chalmers J; Badve SV; Kotwal SS; Ronksley P; Gallagher M; Jun M, 2025, 'Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset', Lancet Regional Health Western Pacific, 57, http://dx.doi.org/10.1016/j.lanwpc.2025.101541

Siriwardana A; Buizen L; Jun M; Kotwal S; Arnott C; Jardine MJ; Levin A; Heerspink HJL; Charytan DM; Pollock C; Perkovic V; Neuen BL, 2025, 'Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial', Diabetes Obesity and Metabolism, 27, pp. 1972 - 1979, http://dx.doi.org/10.1111/dom.16190

Kolovos P; Davies CE; Kholmurodova F; Irish G; Kulkarni H; Polkinghorne KR; Dendle C; Pilmore A; Potter D; Roberts M; Thomas S; Kotwal S; Menahem S, 2025, 'Risk factors associated with 30-day mortality following COVID-19 infection in patients receiving kidney replacement therapy in Australia and New Zealand', Internal Medicine Journal, 55, pp. 622 - 629, http://dx.doi.org/10.1111/imj.16628

Chan B; Varghese A; Badve SV; Pecoits-Filho R; Guedes M; Arnott C; Kozor R; O'Lone E; Jun M; Kotwal S; Block GA; Chertow GM; Solomon SD; Vaduganathan M; Perkovic V; Neuen BL, 2025, 'Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD', Kidney International Reports, 10, pp. 1037 - 1049, http://dx.doi.org/10.1016/j.ekir.2025.01.029

Kotwal SS; Perkovic V, 2025, 'Effects of Semaglutide on CKD in Patients With Type 2 Diabetes', Kidney International Reports, 10, pp. 287 - 290, http://dx.doi.org/10.1016/j.ekir.2024.11.1365

HA JT; FLETCHER RA; ARNOTT C; JUN MIN; KOTWAL SS; PERKOVIC V; BADVE SV; NEUEN BL, 2025, 'Albuminuria, Kidney Function and Heart Failure Risk in Type 2 Diabetes: Participant-level Pooled Analysis from the CANVAS Program and CREDENCE Trial', Journal of Cardiac Failure, http://dx.doi.org/10.1016/j.cardfail.2025.05.021

Ketema DB; Joshi R; Hailu W; Gallagher M; Kotwal S; Jun M, 2025, 'Availability and readiness of health facilities for chronic kidney disease, diabetes and cardiovascular disease in Ethiopia: Evidence from service provision assessment data', Diabetes Obesity and Metabolism, http://dx.doi.org/10.1111/dom.70268

Alessi F; Pamporaki C; Peitzsch M; Constantinescu G; Remde H; Kürzinger L; Fuss CT; Schulze M; Fuld S; Kotwal S; Yang J; Reincke M; Beuschlein F; Lenders JWM; Eisenhofer G, 2025, 'Mass Spectrometric Measurements of 11-Deoxycortisol, Androstenedione and Dehydroepiandrosterone Are Superior to Cortisol to Assess Selectivity of Non-Stimulated Adrenal Vein Sampling', Clinical Endocrinology, http://dx.doi.org/10.1111/cen.70037

Kotwal SS; Du R; Shah NA, 2025, 'A K-ritical Review: Safety of Potassium Intake in CKD: A Systematic Review and Synthesis Without Meta-Analysis (SWiM)', Journal of the American Society of Nephrology, 36, http://dx.doi.org/10.1681/asn.2025hxrhgbc2

Yin X; Huang L; Tian M; Song H; Jha V; Kotwal S; Marklund M; Liu Y; Zhang X; Wu Y; Trieu K; Neal B, 2025, 'Abstract FR559: Risks of hyperkalaemia with potassium-enriched salt substitute among patients using concomitant blockade of the renin-angiotensin-aldosterone system in the Salt Substitute and Stroke Study', Hypertension, 82, http://dx.doi.org/10.1161/hyp.82.suppl_1.fr559

Mottl AK; Mastroianni-Kirsztajn G; Noronha IL; Lim SK; Gorriz JL; Kotwal SS; Kim SG; Barratt J; Brahmbhatt Y; Housler GJ; Jiao R; Heerspink HJL, 2025, 'Baseline Characteristics of ASSIST: Phase 2 Crossover Trial of Atrasentan in Adults with IgAN on SGLT2 Inhibitors', Journal of the American Society of Nephrology, 36, http://dx.doi.org/10.1681/asn.20251m9dyn78

Kotwal SS; Shah NA; Gallagher MP, 2025, 'Eye on AKI: Are Shifting Trends the Cue for a Platform Clinical Trial?', Journal of the American Society of Nephrology, 36, http://dx.doi.org/10.1681/asn.2025g32e9gww

Kotwal SS; Jeyaruban AS; Bose B; Lee VWS; Jardine M; Mallawaarachchi A; Ritchie AG; Wong MG; Makris A; Badve S; Siriwardana A; Yong K; Perkovic V, 2025, 'Glomerular Disease Registry and Biobank: Baseline and Follow-Up Results', Journal of the American Society of Nephrology, 36, http://dx.doi.org/10.1681/asn.2025a2e9nynn

Ketema DB; Buizen L; Wallace H; Ha JTK; Neuen BL; Sasaki T; Jardine M; Kotwal SS; Kosugi T; Ronksley PE; Woodward M; Jun M, 2025, 'Incidence of CKD in Australian Primary Care: Analysis of a National Primary Care Dataset', Journal of the American Society of Nephrology, 36, http://dx.doi.org/10.1681/asn.2025fcqchx75

Ha J; Buizen L; Wallace H; Ketema D; Sasaki T; Arnott C; Badve S; Costa J; Falster M; Gallagher M; Milder T; Pearson S; Kotwal S; Ronksley P; Woodward M; Neuen B; Jun M, 2025, 'Prevalence, Overlap, and Treatment of Cardiovascular-Kidney-Metabolic Conditions in Australian Primary Care: Estimates From a National General Practice Dataset', Heart, Lung and Circulation, 34, pp. S529 - S529, http://dx.doi.org/10.1016/j.hlc.2025.06.676

Wallace H; Buizen L; Badve S; Ha JTK; Ketema DB; Ronksley PE; Sasaki T; Harris K; Henry A; Woodward M; Kotwal SS; Jun M, 2025, 'Sex-Related Differences in CKD Monitoring and Cardiovascular Risk Management in Australian Primary Care: A Retrospective Cohort Study', Journal of the American Society of Nephrology, 36, http://dx.doi.org/10.1681/asn.2025qfjjvkhp

Sasaki T; Buizen L; Harris K; Badve S; Chalmers JP; Gallagher MP; Ha JTK; Jardine M; Ketema DB; Kotwal SS; Neuen BL; Ronksley PE; Wallace H; Yokoo T; Woodward M; Jun M, 2025, 'Variability in eGFR and Adverse Kidney Outcomes in Routine Clinical Practice', Journal of the American Society of Nephrology, 36, http://dx.doi.org/10.1681/asn.2025wn84xd9r

Ketema D; Joshi R; Kotwal S; Hailu W; Gallager M; Jun M, 2025, 'WCN25-1537 ASSESSING THE EPIDEMIOLOGY OF CHRONIC KIDNEY DISEASE IN ETHIOPIA USING A POPULATION-BASED NATIONAL ADMINISTRATIVE DATA SOURCE', Kidney International Reports, 10, pp. S287 - S287, http://dx.doi.org/10.1016/j.ekir.2024.11.534

Kotwal S; Jeyaruban A; Bose B; Lee V; Jardine M; MALLAWARCHCHI A; Ritchie A; Wong M-G; Makris A; Badve S; Siriwardana A; Yong K; Perkovic V, 2025, 'WCN25-1567 Glomerular disease registry and Biobank (GRIT)– design and baseline results', Kidney International Reports, 10, pp. S196 - S197, http://dx.doi.org/10.1016/j.ekir.2024.11.382

Kotwal S; Perkovic V; Jardine M; Vart P; Wheeler D; de Boer I; Zhang H; Hou FF; Sugawara Y; De Nicola L; Gorriz J; Heerspink H, 2025, 'WCN25-1572 DESIGN AND BASELINE CHARACTERISTICS OF THE GLOBAL KIDNEY PATIENT TRIALS NETWORK', Kidney International Reports, 10, pp. S287 - S288, http://dx.doi.org/10.1016/j.ekir.2024.11.535

Kotwal SS; Perkovic V; Jardine MJ; Kim D; Shah NA; Lin E; Coggan S; Billot L; Vart P; Wheeler DC; De Boer IH; Zhang H; Hou FF; Sugawara Y; Marion J; Lewis RJ; Berry LR; McGlothlin A; Jha V; De Nicola L; Gorriz JL; Heerspink HJL, 2024, 'The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design: A Trial Protocol', JAMA Network Open, 7, http://dx.doi.org/10.1001/jamanetworkopen.2024.49998

O'Hara DV; Bassi A; Wilcox A; Jha V; Rathore V; D'Cruz S; Snelling TL; Jones M; Totterdell J; Bangi A; Jain MK; Pollock C; Burrell L; Fox G; Jones C; Kotwal S; Omar SFS; Jardine M; Rathore V; Jones M; Bathla N; Diamante K; Mercade GE; Xie R; Nair A; Decaria A; Abignano N; Jindal A; Siddiqui S; Patel S; Sahu A; Shaikh Y; Jain M; Soni K; Kanje SR; Vimal SK; Kalyan Chakravarthy K; Sathish Babu P; D’Cruz S; Cheema YS; Moni M; Nair SG; Haynes R; Kang G; Thwaites G; Staplin N; Heritier S, 2024, 'Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-081790

Kotwal SS; Dip G; Perkovic V, 2024, 'Kidney Disease as a Cardiovascular Disease Priority', Circulation, 150, pp. 975 - 977, http://dx.doi.org/10.1161/CIRCULATIONAHA.124.068242

Lazarus B; Kotwal S; Gallagher M; Gray NA; Coggan S; Talaulikar G; Polkinghorne KR, 2024, 'Replacement Strategies for Tunneled Hemodialysis Catheters with Complications: A Nationwide Cohort Study', Clinical Journal of the American Society of Nephrology, 19, pp. 1148 - 1158, http://dx.doi.org/10.2215/CJN.0000000000000495

Tangri N; Ferguson TW; Bamforth RJ; Leon SJ; Arnott C; Mahaffey KW; Kotwal S; Heerspink HJL; Perkovic V; Fletcher RA; Neuen BL, 2024, 'Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial', Diabetes Obesity and Metabolism, 26, pp. 3371 - 3380, http://dx.doi.org/10.1111/dom.15678

Catiwa J; Gallagher M; Talbot B; Kerr PG; Semple DJ; Roberts MA; Polkinghorne KR; Gray NA; Talaulikar G; Cass A; Kotwal S; Tombocon O; Walker R; Wilson S; Balakrishnan SK; Fernandes D; Kulkarni H; Light C; Ryan J; Marsh E; Wei J; Lleva V; Mwangi L; Mount P; Ross-Smith M; Veenendaal M; Smith V; Somerville C; Davidson-West S; Grainer N; Green S; Mantha M; Thiessen K; Winsbury A; Yao I; Neville E; Marquez K; Razavian M; Tienstra L; Stewart G; Chan C; McLean P; McMahon L; Roberts M; Chang M; Chiam A; Wright D; O'Brien O; Swaminathan R; Wimalasena S; Puttagunta H; Barbara J; Luke A; Pummeroy M; Torpey K; Nicholls G; Swinbank A; Titus T; Bell J; Johnson D; Choi P; Chu G; Garvey L; Gillies A; Chow J; De Guzman I; Gando J; Wong J; Nguyen R; Cherian R; Gillard R; James R; Burke M; Glancy L; Lewis S; Baer R; Wade S; Lin D; Ngwenya F; Narayanankutty A; Fitt K; Seneviratne M; Komala M; McCourt J; Lawlor C; Kelleher M; Coburn A; Guo S; Sudak J; Leary D; Anderson J; Han T; Titmarsh T; Adam E; Hockley B; Latte J; Matthew Y; McDonald S, 2024, 'Clinical Adjudication of Hemodialysis Catheter-Related Bloodstream Infections: Findings from the REDUCCTION Trial', Kidney360, 5, pp. 550 - 559, http://dx.doi.org/10.34067/KID.0000000000000389

Lazarus B; Polkinghorne KR; Gallagher M; Coggan S; Gray NA; Talaulikar G; Kotwal S, 2024, 'Tunneled Hemodialysis Catheter Tip Design and Risk of Catheter Dysfunction: An Australian Nationwide Cohort Study', American Journal of Kidney Diseases, 83, pp. 445 - 455, http://dx.doi.org/10.1053/j.ajkd.2023.09.021

Kim D; Perkovic V; Kotwal S, 2024, 'Barriers to Care: New Medications and CKD', Kidney International Reports, 9, pp. 504 - 507, http://dx.doi.org/10.1016/j.ekir.2023.12.012

Neuen BL; Jun M; Wick J; Kotwal S; Badve SV; Jardine MJ; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley PE, 2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data', Lancet Regional Health Western Pacific, 43, http://dx.doi.org/10.1016/j.lanwpc.2023.100988

Jun M; Wick J; Neuen BL; Kotwal S; Badve SV; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine MJ; Perkovic V; Gallagher M; Ronksley PE, 2024, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports, 9, pp. 312 - 322, http://dx.doi.org/10.1016/j.ekir.2023.11.022

Kotwal S; Perkovic E; Perkovic V, 2024, 'Combination therapy with kidney protective therapies: Optimizing the benefits?', Current Opinion in Nephrology and Hypertension, 33, pp. 136 - 143, http://dx.doi.org/10.1097/MNH.0000000000000929

Ketema DB; Wallace H; Neuen BL; Kotwal SS; Ronksley PE; Badve S; Perkovic V; Gallagher MP; Joshi R; Jun M, 2024, 'Assessing the Quality of Care for People with CKD: A Systematic Review and MetaAnalysis', JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 35, http://dx.doi.org/10.1681/ASN.2024bzcfkb63

Siriwardana A; Jardine M; Perkovic V; Jun M; Kotwal SS; Arnott CG; Neuen BL, 2024, 'Cardiovascular, Kidney, and Safety Outcomes with Canagliflozin in Older Adults: A Pooled Secondary Analysis of the CANVAS Program and CREDENCE Trial', JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 35, http://dx.doi.org/10.1681/ASN.2024e59ygyz9

Catiwa J; Gallagher MP; Jan S; Polkinghorne K; Gray NA; Higgins K; Kotwal SS, 2024, 'National Estimates of Direct Health Care Costs Associated with Catheter-Related Bloodstream Infection among Hospitalized Hemodialysis Patients in Australia', JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 35, http://dx.doi.org/10.1681/ASN.20246pgrza9p

Yeung EK; Ferguson TW; Tangri N; Vaduganathan M; Arnott CG; Jun M; Kotwal SS; Jardine M; Perkovic V; Heerspink HJL; Neuen BL, 2024, 'Risk-Based Implementation of SGLT2 Inhibitors: Insights from the CANVAS Program and CREDENCE Trial', JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 35, http://dx.doi.org/10.1681/ASN.2024k6fn2ax5

Wallace H; Wick J; Ketema DB; Neuen BL; Jardine M; Lin J; Nelson CL; Pearson S; Peiris D; Woodward M; Ronksley PE; Gallagher MP; Kotwal SS; Jun M, 2024, 'Use of SGLT2 Inhibitors and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Australian Primary Care Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by CKD Status', Journal of the American Society of Nephrology, 35, pp. 10.1681/asn.2024f7q40fk1, http://dx.doi.org/10.1681/asn.2024f7q40fk1

Back to profile page